AI Analysis
switching costsmedium conviction
GitLab at $8B mcap and P/S of 7.6x (slight premium to sector median 6.7x) is arguably fair for 21% revenue growth with a genuinely defensible DevSecOps platform. Path to 5x: $8B → $40B requires $4-5B revenue at 9-10x P/S, achievable from $1.1B TTM at ~25% CAGR over 5 years. The bull case hinges on AI-assisted development (GitLab Duo) driving expansion into existing enterprise accounts — if net dollar retention trends upward, the revenue CAGR is achievable. FCF neutral at -0% is a positive; zero debt is rare and valuable at current interest rates.
Based on Q3 2026 financials (data: 2026-11-09)
Catalysts
- • GitLab Duo AI coding assistant competing directly with GitHub Copilot — differentiation on security-first, integrated DevOps platform for regulated industries
- • Enterprise land-and-expand: existing customer base monetization through Duo Pro/Enterprise tiers could drive net retention above 125%
- • GTLB down 13.5% in 5 days — if driven by broader tech selloff (VIX 25.6) rather than company-specific news, this is an entry point
Risks
- • GitHub (Microsoft-backed) is the dominant competitor with massive distribution advantage and comparable AI features — moat is real but under sustained attack
- • GAAP operating margin of -12% is a concern; SBC/Rev at 22% means non-GAAP margin is ~+10%, but GAAP losses limit institutional ownership
- • 1.7% annual dilution is manageable but SBC at 22% of revenue is elevated for a company this size
- • No PE, No PEG available — earnings path unclear; loss of key enterprise deals could cause sharp re-rating
AI Deep Dive
10/10 today
Generate an AI-powered deep dive analysis for GTLB.
GTLB
GitLab
$47.33
Current Price
$18.7352-Week Range$58.01
Researched today
Score History
Score Breakdown
68
Composite
Multi-Bagger
30%71
Valuation
25%91
Growth
20%32
Profitability
15%59
Health
10%85
Fundamentals
Revenue Growth (YoY)21.3%
Earnings Growth (YoY)-300.1%
Gross Margin85.9%
Operating Margin-6.1%
FCF Margin-0.3%
Free Cash Flow$-3.3M
SBC / Revenue21.8%
Share Dilution (ann.)1.7%
Valuation
P/E Ratio--
P/S Ratio7.47x
PEG Ratio--
EV/EBITDA-112.35x
Financial Health
Debt/Equity
0.00xCurrent Ratio
2.54xFree Cash Flow
$-3.3M